Machine Learning Uncovers Unknown Bacterial Features Monday, January 25, 2016 Technique robustly identified characteristic gene expression patterns in response to antibiotics, low oxygen conditions.CRISPR-Cas9 Gene Editing Advances Again Thursday, January 21, 2016 UC Berkeley researchers have made a major improvement in CRISPR-Cas9 technology that achieves an unprecedented success rate of 60 percent when replacing a short stretch of DNA with another.Disrupting Cell’s Supply Chain Freezes Cancer Virus Thursday, January 21, 2016 When the cancer-causing Epstein-Barr virus moves into a B-cell of the human immune system, it tricks the cell into rapidly making more copies of itself, each of which will carry the virus. Biovest International Spins off Cell Culture Company Thursday, January 21, 2016 Biovest International Inc. announced that it will spin off its instrument and contract manufacturing offerings into a single wholly-owned subsidiary named “Cell Culture Company, LLC.” InSphero Adds Head of Sales Thursday, January 21, 2016 Beate Schnell, Ph.D. joins senior team at global leader in 3D cell culture, new hires announced to support US and European growth.Pall, Kaneka Enter Agreement Wednesday, January 20, 2016 Pall Corporation announced the signing of a supply agreement for KANEKA KanCapA Japan for the primary capture of monoclonal antibodies from clarified cell culture. Why Do Some Infections Persist? Friday, January 15, 2016 In preparing for the possibility of an antibiotic onslaught, some bacterial cultures adopt an all-for-one/one-for-all strategy that would make a socialist proud, University of Vermont researchers have found. ASCB: A CELLebration of Cell Biology Tuesday, January 12, 2016 The last major congress of the year, ASCB is less a platform for launching new products, but one for confirming and consolidating the trends that have emerged over the past 12 months. Squeezing Cells into Stem Cells Tuesday, January 12, 2016 EPFL scientists have developed a new method that helps cells turn in usable stem cells. The new approach involves “squeezing” cells with a gel, and paves the way for large-scale production of stem cells for medical purposes.